Results for national institute virology

Add to feed Create your own feed

Latest

India's premier medical body ICMR has said 12 clinical trial sites for the indigenous Covaxin, being developed in collaboration with the Hyderabad-based Bharat Biotech and the National Institute of Virology (NIV), have been identified.

#ExpressFrontPage | The potential vaccine is being developed by Bharat Biotech, a Hyderabad-based pharmaceutical company, in partnership with Pune-based National Institute of Virology, an ICMR laboratory

#Covaxin , the vaccine in question, has been developed b #BharatBiotech  in collaboration with the National Institute of Virology #NIV (), which is a part of the Indian Council of Medical Research #ICMR ()

#EXCLUSIVE | We have been working day and night for the last 3-4 months on this vaccine with ICMR and National Institute of Virology, Pune: @DrKrishnaElla  (CMD, Bharat Biotech) speaks to @snehamordani . #IndiaFightsCOVID19 

The National Botanical Research Institute (NBRI), Lucknow, under @IndiaDST , has established an 'Advanced Virology Lab' for testing #COVID19 . The facility has been developed based on the guidelines of @MoHFW_INDIA , the @ICMRDELHI , and the @WHO . @csirnbrilko  #IndiaFightsCorona 

tweet picture

#EXCLUSIVE | We have been working day and night for the last 3-4 months on this vaccine with ICMR and National Institute of Virology, Pune: @DrKrishnaElla  (CMD, Bharat Biotech) speaks to @snehamordani . #IndiaFightsCOVID19 

India’s first COVID-19 vaccine candidate COVAXIN gets DCGI approval. Developed by Bharat Biotech, in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology #COVID  #COVID191  @CNBCTV18Live9 

Indian vaccine manufacturer Bharat Biotech has announced obtaining the #DCGI  approvals to initiate phase-I and II human clinical trials for #Covid19  vaccine it developed in collaboration with the National Institute of Virology, part of ICMR

National Botanical Research Institute, Lucknow establishes Advanced Virology Lab for testing #COVID-19 . Advanced Virology Lab is Bio Safety Level- 3 facility & has suction facility that can suck any aerosol, pass it through filters.

Loading
Loading

Most relevant

National Institute of Virology, Pune has successfully developed the 1st indigenous anti-SARS-CoV-2 human IgG ELISA test kit for antibody detection of #COVID19  . This robust test will play a critical role in surveillance of proportion of population exposed to #SARSCoV2  infection

tweet picture

National Institute of Virology, Pune has successfully developed the 1st indigenous anti-SARS-CoV-2 human IgG ELISA test kit for antibody detection of #COVID19 . It will play a critical role in surveillance of proportion of population exposed to the infection: Union Health Minister

tweet picture

National Institute of Virology, Pune, has developed first indigenous antibody-based ELISA test kit, #COVIDKAVACH , for diagnosis of novel #CoronaVirus . This test is expected to change the dynamics of COVID-19 testing in the country.

tweet picture

Till date, 16 antibody based rapid tests have been validated at National Institute of Virology (NIV), Pune and the following 8 were found to be satisfactory: Indian Council of Medical Research (ICMR) #COVID19 

tweet picture

National Institute of Virology (NIV), Pune has validated 7 antibody-based rapid tests and found them to be satisfactory. #COVID19 

tweet picture

Story of a woman scientist to cheer us all up. Virologist Minal Dakhave Bhosale finished creating a new testing kit for Covi-19 in ‘’record time’’ at the National Institute of Virology in Pune, a mere 24 hours before giving birth to her daughter!

Just in: India is the 5th country globally to isolate the COVID-19 virus strain. The isolation by ICMR’s National Institute of Virology will help in future development of drugs, vaccines and rapid diagnostic kits, @BShajan  reports. #CoronavirusPandemic 

Scientists at the National Institute of Virology, Pune isolate 11 strains of the #COVID19 . India becomes fifth country to successfully isolate virus strain after Japan, Thailand, United States and China.

Loading
Loading